See All Slides - tctmd.com

Slides

Presentation Cell Therapy 2014

MEta-Analysis of Stem Cell Studies (MESS) In Ischemic Heart Disease Using Patient-Specific Data

Presenter: Mariann Gy?ngy?si

January 23, 2014

Presentation Advances in Hemodynamic Support 2014

Update on Impella Data with Cardiogenic Shock

Presenter: Jeffrey W. Moses

January 23, 2014

Presentation Cell Therapy 2014

HGF for Critical Limb Ischemia

Presenter: Emerson C. Perin

January 22, 2014

Presentation Cell Therapy 2014

Biological and pre-clinical characterization of CD34+ cells before and after automated GMP Expansion as a pre-requisite for launching the EXCELLENT clinical trial

Presenter: Philippe Henon

January 22, 2014

Presentation Cell Therapy 2014

RETRO-HF

Presenter: Amit N. Patel

January 22, 2014

Presentation Cell Therapy 2014

Connexin 43 transfected skeletal myoblasts in patients with CHF

Presenter: Maciej Kurpisz

January 22, 2014

Presentation Cell Therapy 2014

MPC’s for Ischemic and Non-ischemic Heart Failure

Presenter: Emerson C. Perin

January 22, 2014

Presentation Cell Therapy 2014

Clinical Trials in Peripheral Arterial Disease

Presenter: Keith L. March

January 22, 2014

Presentation Cell Therapy 2014

Gene Modified EPCs for STEMI

Presenter: Michael Kutryk

January 22, 2014

Presentation Cell Therapy 2014

Safety and Feasibility Trial of Adipose Derived Regenerative Cells in Treatment of Chronic Myocardial Ischemia (ATHENA)

Presenter: Emerson C. Perin

January 22, 2014

Advertisement

Slides

MEta-Analysis of Stem Cell Studies (MESS) In Ischemic Heart Disease Using Patient-Specific Data

Update on Impella Data with Cardiogenic Shock

HGF for Critical Limb Ischemia

Biological and pre-clinical characterization of CD34+ cells before and after automated GMP Expansion as a pre-requisite for launching the EXCELLENT clinical trial

RETRO-HF

Connexin 43 transfected skeletal myoblasts in patients with CHF

MPC’s for Ischemic and Non-ischemic Heart Failure

Clinical Trials in Peripheral Arterial Disease

Gene Modified EPCs for STEMI

Safety and Feasibility Trial of Adipose Derived Regenerative Cells in Treatment of Chronic Myocardial Ischemia (ATHENA)

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content